0.90
+0.2573(+40.10%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.98 |
| Day High | 1.17 |
| Day Low | 0.81 |
| 52-Week High | 274.5 |
| 52-Week Low | 0.57 |
| Volume | 194.9M |
| Average Volume | 4.1M |
| Market Cap | 2.74M |
| PE | -0.01 |
| EPS | -142.21 |
| Moving Average 50 Days | 1.63 |
| Moving Average 200 Days | 29.95 |
| Change | 0.26 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $0.06 as of September 18, 2025 at a share price of $0.899. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 2 years ago, it would be worth $0.05 as of September 18, 2025 at a share price of $0.899.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CDT Executes Cryptocurrency Treasury Reserve Strategy
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
Initial digital asset acquisition marks milestone in capital diversification initiativeNAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced the strateg
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
GlobeNewswire Inc.
Sep 03, 2025 12:30 PM GMT
Cryptocurrency treasury reserve strategy is designed to diversify capital structure while reinforcing CDT's innovation-led modelNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or t
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
GlobeNewswire Inc.
Aug 26, 2025 12:30 PM GMT
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial dataNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT)